InvestorsHub Logo
Followers 79
Posts 24638
Boards Moderated 1
Alias Born 09/08/2000

Re: None

Thursday, 04/18/2024 9:09:54 AM

Thursday, April 18, 2024 9:09:54 AM

Post# of 27556
BPTH - 5.30/5.34 Up from yesterday's close of 3.24

Bio-Path Holdings Announces Completion Of Higher Dose Second Cohort In Phase 1/1b Clinical Trial Of BP1002 In Refractory/Relapsed Acute Myeloid Leukemia Patients

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.